Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
Estimates Beat
|
Expensive Star
6656.5000
-227.00
(
-3.30
%)
NSE
Nov 07, 2025
15:31 PM
34.34% Gain from 52W Low
Volume:
855.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
04 Feb 2023
Estimates Beat
6656.50
-3.30%
Lower realization in API sales/ reduced operating leverage drag earnings
Neutral:
Divi's Laboratories Ltd.
by
Motilal Oswal
Target: 2620
Recommendation
Target
Motilal Oswal
Divi's Laboratories .. has an
average target
of 6414.33 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
Five Interesting Stocks Today - November 7, 2025
The Baseline |
07 Nov 2025, 04:49PM
Market closes lower, NHPC's Q2 net profit grows 12% YoY
Trendlyne Marketwatch |
07 Nov 2025, 04:12PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022